DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20212829

Microbiological etiology and management approach of febrile neutropenia

Omar Rezk Alshaer, Abdullah Obaid Binobaid, Yousef Hussain Alharthi, Abdulaziz Ashwa Alrashdi, Muath Saleh Alrashed, Fahad Barikan Alluhayyan, Khuzama Abdullah Alghasham, Abdulrahman Abdullah Alqifari, Riam Saleh Alkhamis, Maryiah Abdulaziz Alhajji, Noura Talal Almutairi

Abstract


Many etiologies have been proposed to predispose neutropenic fever, and infections have been reported in less than one-third of the reported cases. However, etiologies might have a significant impact on the prognostic, and can even lead to mortality. In this literature review, the aim to discuss the different microbiological etiologies of neutropenic fever, and the management approaches of such conditions, including the proper assessment and evaluation of patients. Additionally, the goal of this literature review to discuss the appropriate treatment and prophylaxis measures based on the assessment results. Many bacterial pathogens could be isolated from patients suffering from neutropenic fever, including both the gram-positive and negative organisms, such as pseudomonas aeruginosa, E. coli, Klebsiella spp, actinobacteria spp, in addition to many other bacteria such as staph. Nevertheless, Aureus was commonly isolated from the infected patients, and it has been reported with increased morbidity and mortality rates. Assessment of the severity of the condition and identification of the microbiological activity can significantly lead to enhance management of the infected patients. Detailed information about the etiology and management are provided within the main text of this study. Further efforts are needed to increase awareness related to the hazards of the inadequate and incomplete assessments of patients with neutropenic fever, which might lead to delayed or inadequate management and worsened prognosis.


Keywords


Microbiology, Management, Culture, Neutropenic fever, Critically ill

Full Text:

PDF

References


Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of america. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2011;52(4):e56-93.

Klastersky J. Management of fever in neutropenic patients with different risks of complications. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2004;39(1):S32-7.

Jacob LA, Lakshmaiah KC, Govindbabu K. Clinical and microbiological profile of febrile neutropenia in solid tumors and hematological malignancies at a tertiary cancer care center in South India. Indian journal of cancer. 2014;51(4):464-8.

Hakim H, Flynn PM, Knapp KM, Srivastava DK, Gaur AH. Etiology and clinical course of febrile neutropenia in children with cancer. Journal of pediatric hematology/oncology. 2009;31(9):623-29.

Lucas AJ, Olin JL, Coleman MD. Management and Preventive Measures for Febrile Neutropenia. P & T: a peer-reviewed journal for formulary management. 2018;43(4):228-32.

Liu CY, Lai YC, Huang LJ. Impact of bloodstream infections on outcome and the influence of prophylactic oral antibiotic regimens in allogeneic hematopoietic SCT recipients. Bone marrow transplantation. 2011;46(9):1231-9.

Penack O, Becker C, Buchheidt D. Management of sepsis in neutropenic patients: 2014 updated guidelines from the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO). Annals of hematology. 2014;93(7):1083-95.

Jeddi R, Achour M, Amor RB. Factors associated with severe sepsis: prospective study of 94 neutropenic febrile episodes. Hematology (Amsterdam, Netherlands). 2010;15(1):28-32.

Kang CI, Song JH, Chung DR. Risk factors and pathogenic significance of severe sepsis and septic shock in 2286 patients with gram-negative bacteremia. The Journal of infection. 2011;62(1):26-33.

El-Qushayri AE, Khalaf KM, Dahy A. Fournier's gangrene mortality: A 17-year systematic review and meta-analysis. Int J Infect Dis. 2020;92:218-25.

Ghozy S, Tran L, Naveed S. Association of breastfeeding status with risk of autism spectrum disorder: A systematic review, dose-response analysis and meta-analysis. Asian J Psychiatr. 2020;48:101916.

Mandal PK, Maji SK, Dolai TK. Micro-organisms Associated with Febrile Neutropenia in Patients with Haematological Malignancies in a Tertiary Care Hospital in Eastern India. Indian J Hematol Blood Transfus. 2015;31(1):46-50.

Cometta A, Zinner S, de Bock R. Piperacillin-tazobactam plus amikacin versus ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Antimicrobial agents and chemotherapy. 1995;39(2):445-52.

Cometta A, Calandra T, Gaya H. Monotherapy with meropenem versus combination therapy with ceftazidime plus amikacin as empiric therapy for fever in granulocytopenic patients with cancer. The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer and the Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto Infection Program. Antimicrobial agents and chemotherapy. 1996;40(5):1108-15.

Elting LS, Rubenstein EB, Rolston KV, Bodey GP. Outcomes of bacteremia in patients with cancer and neutropenia: observations from two decades of epidemiological and clinical trials. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1997;25(2):247-59.

Hughes WT, Armstrong D, Bodey GP. 2002 guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2002;34(6):730-51.

Hughes WT, Armstrong D, Bodey GP. 1997 guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. Infectious Diseases Society of America. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1997;25(3):551-73.

Sood P, Seth T, Kapil A. Emergence of multidrug resistant acinetobacter blood stream infections in febrile neutropenia patients with haematological cancers and bone marrow failure syndromes. Journal of the Indian Medical Association. 2012;110(7):439-44.

Paul M, Bhatia M, Rekha US, Diksha, Omar BJ, Gupta P. Microbiological Profile of Blood Stream Infections in Febrile Neutropenic Patients at a Tertiary Care Teaching Hospital in Rishikesh, Uttarakhand. J Lab Physicians. 2020;12(2):147-53.

Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Annals of internal medicine. 1966;64(2):328-40.

Cordonnier C, Herbrecht R, Pico JL. Cefepime/amikacin versus ceftazidime/amikacin as empirical therapy for febrile episodes in neutropenic patients: a comparative study. The French Cefepime Study Group. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1997;24(1):41-51.

Glauser M, Boogaerts M, Cordonnier C, Palmblad J, Martino P. Empiric therapy of bacterial infections in severe neutropenia. Clinical Microbiology and Infection. 1997;3:s77-86.

Eggimann P, Garbino J, Pittet D. Epidemiology of Candida species infections in critically ill non-immunosuppressed patients. The Lancet Infectious diseases. 2003;3(11):685-702.

Ostrosky-Zeichner L, Pappas PG. Invasive candidiasis in the intensive care unit. Critical care medicine. 2006;34(3):857-63.

Engelhard D, Elishoov H, Strauss N. Nosocomial coagulase-negative staphylococcal infections in bone marrow transplantation recipients with central vein catheter. A 5-year prospective study. Transplantation. 1996;61(3):430-34.

Viscoli C, Castagnola E, Giacchino M. Bloodstream infections in children with cancer: a multicentre surveillance study of the Italian Association of Paediatric Haematology and Oncology. Supportive Therapy Group-Infectious Diseases Section. European journal of cancer. 1999;35(5):770-74.

Madani TA. Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection. 2000;28(6):367-73.

Ninin E, Milpied N, Moreau P. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2001;33(1):41-7.

Reed EC. Infectious complications during autotransplantation. Hematology/oncology clinics of North America. 1993;7(3):717-35.

Bochud PY, Eggiman P, Calandra T, Van Melle G, Saghafi L, Francioli P. Bacteremia due to viridans streptococcus in neutropenic patients with cancer: clinical spectrum and risk factors. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 1994;18(1):25-31.

Kern W, Kurrle E, Schmeiser T. Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases. Infection. 1990;18(3):138-45.

Karanwal AB, Parikh BJ, Goswami P, Panchal HP, Parekh BB, Patel KB. Review of clinical profile and bacterial spectrum and sensitivity patterns of pathogens in febrile neutropenic patients in hematological malignancies: A retrospective analysis from a single center. Indian journal of medical and paediatric oncology: official journal of Indian Society of Medical & Paediatric Oncology. 2013;34(2):85-8.

Klastersky J, de Naurois J, Rolston K. Management of febrile neutropaenia: ESMO Clinical Practice Guidelines. Annals of oncology: official journal of the European Society for Medical Oncology. 2016;27(suppl 5):v111-8.

Ferreira JN, Correia L, Oliveira RM, Watanabe SN, Possari JF, Lima AFC. Managing febrile neutropenia in adult cancer patients: an integrative review of the literature. Revista brasileira de enfermagem. 2017;70(6):1301-8.

Karimi F, Ashrafi F, Moghaddas A, Derakhshandeh A. Management of Febrile Neutropenia: A Description of Clinical and Microbiological Findings by Focusing on Risk Factors and Pitfalls. J Res Pharm Pract. 2018;7(3):147-56.

Libuit J, Whitman A, Wolfe R, Washington CS. Empiric vancomycin use in febrile neutropenic oncology patients. Open forum infectious diseases. 2014;1(1):ofu006.

Villafuerte-Gutierrez P, Villalon L, Losa JE, Henriquez-Camacho C. Treatment of febrile neutropenia and prophylaxis in hematologic malignancies: a critical review and update. Advances in hematology. 2014;2014:986938.

Chung SJ, Miller RA, Permpalung N. Fluoroquinolone prophylaxis reduces febrile neutropenia, bloodstream infections from mucosal translocations, and intensive care admissions in high risk hematological patients, a single center experience. Leukemia & lymphoma. 2019;60(2):488-92.

Yoshida M, Ohno R. Antimicrobial prophylaxis in febrile neutropenia. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America. 2004;39(1):S65-67.

Neumann S, Krause SW, Maschmeyer G, Schiel X, von Lilienfeld-Toal M. Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematological malignancies and solid tumors : guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO). Annals of hematology. 2013;92(4):433-42.

Thieu H, Bach Dat B, Nam NH. Antibiotic resistance of Helicobacter pylori infection in a children's hospital in Vietnam: prevalence and associated factors. Minerva medica. 2020;111(5):498-501.

Hashiguchi Y, Kasai M, Fukuda T, Ichimura T, Yasui T, Sumi T. Chemotherapy-induced neutropenia and febrile neutropenia in patients with gynecologic malignancy. Anti-cancer drugs. 2015;26(10):1054-60.

Jin J, Lee Y, Ding Y. Prospective Audit of Febrile Neutropenia Management at a Tertiary University Hospital in Singapore. Annals of the Academy of Medicine, Singapore. 2010;39:453-9.